Darentang: Proposed transfer of 12% equity interest in Sino-US Tianjin SmithKline Pharmaceutical Co., Ltd. will affect the company's current investment income by approximately RMB 1.54 billion

2025-04-15 17:21:16

Darentang announced that the company intends to transfer its 4.6% and 7.4% equity interests in Sino-US Tianjin SmithKline Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CHSARL, respectively, with the transaction prices being RMB 622 million and RMB 1.001 billion, respectively. According to preliminary calculations, the transaction is expected to affect the company's current investment income by approximately RMB 1.54 billion. After the completion of this transfer, the company will no longer hold shares in Tianjin SmithKline.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Nvidia (NVDA.O): Blackwell chips have begun production at TSMC's chip factory in Phoenix, Arizona.
                            2025-04-14

                                    Li Lecheng, Secretary of the Party Leadership Group of the Ministry of Industry and Information Technology, meets with Sultan, Minister of Industry and Advanced Technology of the United Arab Emirates
                            2025-04-18

                                    BOE A: Net profit is expected to increase by 63% to 68% year-on-year in the first quarter of 2025
                            2025-04-15

                                    Faraday Future (FFIE.O) announced that it firmly opposes reverse stock splits and is committed to maintaining its listing status on Nasdaq. CEO Mark will meet with White House decision makers.
                            2025-04-17

                                    Kugou Music Viper Sound Quality cooperates with MediaTek chips to realize new device-side AI data saving technology
                            2025-04-11